MOTS-c Wikipedia-style overview: what this mitochondrial-derived peptide is, how it works, research findings, dosage, and safety in humans today.
MOTS-c is a 16-amino-acid peptide encoded inside the mitochondrial genome, specifically within the 12S ribosomal RNA region of mitochondrial DNA. Researchers first described it in 2015 as a mitochondrial-derived peptide that helps regulate glucose and lipid metabolism, largely through activation of AMPK. MOTS-c is not FDA-approved for human use, and it is sold only as a research chemical that has been studied mainly in cells and animals.
What Is MOTS-c?
MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA type-c." Unlike most peptides, which come from nuclear DNA, MOTS-c is produced from a short stretch of mitochondrial DNA that scientists once considered non-coding.
Key facts about MOTS-c:
- Size: 16 amino acids, making it one of the smallest known metabolic peptides.
- Origin: Encoded in mitochondrial DNA and produced by mitochondria; it can also travel to the nucleus and influence gene expression.
- Main research interest: Metabolic regulation, insulin sensitivity, and exercise-like effects on muscle.
- Regulatory status: Not approved by the FDA for human use; available only as a research chemical.
Because of how it is named and where it comes from, MOTS-c is frequently confused with better-known compounds in fitness and longevity circles. A mots c wikipedia search usually lands on the same handful of facts: the discovery year, the peptide length, and the AMPK connection.
How MOTS-c Is Thought to Work
Laboratory work shows that MOTS-c activates AMPK, an enzyme that acts as a cellular energy sensor. The peptide also interacts with the folate-methionine cycle and raises levels of AICAR, a molecule that further stimulates AMPK signaling.
Downstream effects reported in animal and cell studies include:
- Improved insulin sensitivity and glucose uptake in skeletal muscle
- Increased fatty acid oxidation
- Reduced inflammatory signaling in some tissue models
- Adaptations that resemble parts of the exercise response
MOTS-c also appears to move from the mitochondria into the nucleus under metabolic stress, where it influences genes involved in antioxidant defense and metabolism. How closely this biology translates to people is still unresolved.
What the Research Actually Shows
Animal and cell studies
In mice, MOTS-c injections have been linked to improvements in diet-induced obesity, glucose tolerance, and physical performance. These are preclinical findings, and results in mice do not automatically carry over to humans.
Human data
Human evidence comes mainly from measuring naturally occurring MOTS-c levels rather than from supplementing the peptide. Circulating MOTS-c has been associated with insulin sensitivity, and levels appear to shift with exercise and age. No published randomized controlled trial has established that supplementing MOTS-c is safe or effective in people.
MOTS-c Compared With Other Research Peptides
People exploring metabolic peptides often compare MOTS-c with compounds that work through entirely different pathways.
| Peptide | Main research focus | Mechanism | Human evidence |
|---|---|---|---|
| MOTS-c | Metabolic regulation, insulin sensitivity | AMPK activation, folate-methionine cycle | Observational only; no published trials |
| AOD-9604 | Fat metabolism | Growth hormone fragment (hGH 176-191) | Some human studies; not FDA-approved |
| SS-31 (elamipretide) | Mitochondrial dysfunction | Binds cardiolipin on the inner membrane | Clinical trials for rare conditions |
| Tesamorelin | Visceral fat in HIV-associated lipodystrophy | GHRH analog | FDA-approved for one indication |
It is common to see aod 9604 vs mots-c comparisons in forum threads, even though the two peptides are studied for different reasons. Some laboratory protocols look at aod-9604 and mots-c together because both are investigated in the context of fat metabolism, but combining them has never been validated in human trials.
Community discussions about aod-9604 mots-c tesamorelin dosage are anecdotal, because only tesamorelin has an approved human dosing schedule — and that schedule applies to a single clinical indication. Some mitochondrial researchers discuss a ss-31 and mots-c protocol as well, though SS-31 targets the inner mitochondrial membrane while MOTS-c works through metabolic and nuclear signaling.
Dosage, Forms, and Legal Status
There is no established human dosage of MOTS-c. Published animal studies typically use subcutaneous or intraperitoneal injections in mice and rats, at doses that cannot be converted directly into human recommendations. Products sold online are labeled "for research use only" and are not intended for human consumption.
Practical points to keep in mind:
- MOTS-c is not an FDA-approved drug, and no pharmacy dispenses it for human use.
- Research chemical suppliers are not required to meet pharmaceutical purity standards.
- Certificates of analysis vary widely in quality, and mislabeled peptides have been documented in the gray market.
- Self-experimentation carries unknown risks, including injection-site reactions and unpredictable effects on glucose metabolism.
Safety and What to Ask a Professional
No human safety data exists for supplemental MOTS-c, so any statement about its risks in people is speculative. Because the peptide influences AMPK and glucose handling, it could theoretically interact with diabetes medications or affect blood sugar in ways that matter.
Anyone considering a research peptide should speak with a physician or pharmacist instead of relying on forum posts. A licensed clinician can review current medications, discuss potential interactions, and explain whether an approved alternative fits your situation.
MOTS-c is a mitochondrial-derived peptide with promising preclinical metabolic data, but it is not an approved therapy and has no established human dose.
Frequently Asked Questions
Is MOTS-c a real peptide?
Yes. MOTS-c is a real 16-amino-acid peptide encoded within the 12S rRNA region of mitochondrial DNA, and it was first described in the scientific literature in 2015. It belongs to a group of compounds known as mitochondrial-derived peptides.
Is MOTS-c FDA-approved for human use?
No. MOTS-c is not FDA-approved for any human condition and is legally sold only as a research chemical in the United States. No pharmacy dispenses it for human use.
Is there a standard MOTS-c dosage for humans?
There is no established human dosage of MOTS-c. Published studies use mice and rats, and those doses cannot be converted into reliable human recommendations. Human research so far has measured naturally occurring MOTS-c levels rather than testing supplemental injections.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.